Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
09/2003
09/11/2003US20030171461 Process for the synthesis of amine ethers from secondary amino oxides
09/11/2003US20030171422 Aldose reductase inhibitors; antidiabetic agents
09/11/2003US20030171415 Strokes; cardiovascular disorders; mixture of melmisartan and ramipril
09/11/2003US20030171377 Therapy for non-insulin dependent diabetes
09/11/2003US20030171354 Indole derivatives
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030171341 Method for modulating the activity of a Rho C enzyme, comprising: contacting said Rho C enzyme with an effective amount of a compound of formula 1:
09/11/2003US20030171219 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
09/11/2003US20030171211 Include a Group 13 atom, preferably boron or aluminum, bonded to at least one heterocyclic groups. The heterocyclic group preferably contains one or more heteroatoms selected from Group 15 and/or 16, and may be unsubstituted or substituted.
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/11/2003US20030170179 As contrast medium for fluorescence and transillumination diagnostics; drugs
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/10/2003EP1341785A2 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341765A1 Therapeutic compounds
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341760A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors
09/10/2003EP1341759A2 3-substituted oxindole beta 3 agonists
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP1296948B1 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
09/10/2003EP1140818B1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase
09/10/2003EP1131321B1 Indole derivatives and their use as serotonin receptor ligands
09/10/2003EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion
09/10/2003EP0939627B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/10/2003EP0896533B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues
09/10/2003CN1120878C Method for coal liquefaction
09/09/2003US6617480 Molecular weight-enlarged ligands for asymmetric, homogeneously soluble hydrogenation catalysts, process for the production thereof and use
09/09/2003US6617460 Process for preparing toluenesulfinates
09/04/2003WO2003072565A1 Process for the production of citalopram
09/04/2003WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003WO2003072532A1 Ester compound and medicinal use thereof
09/04/2003WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/04/2003WO2003072124A1 Induction method for cell differentiation
09/04/2003WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
09/04/2003WO2002009760A9 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
09/04/2003WO2002003977A3 Combinations of statins, estrogenic agents and optionally estrogens
09/04/2003US20030166946 Anticholesterol agents; antilipemic agents; cardiovascular disorders
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166706 Method of treating osteoarthritis
09/04/2003US20030166702 Contacting carvedilol and ethyl acetate to form a solution, and cooling the solution whereby a precipitate is formed; hypotensive agent
09/04/2003US20030166693 Benzene derivatives and pharmaceutical use thereof
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166665 4-,5-,6-And 7-indole derivatives useful for the treatment of CNS disorders
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166649 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166630 Amino acid derivatives and their use as medicines
09/04/2003US20030166615 A phenylamide indole compound derivatives for treating cancer, psoriasis, arteriosclerosis, immune system activity, Type II diabetes, and obesity
09/04/2003US20030166505 Neo-tryptophan
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/04/2003CA2475653A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/04/2003CA2444940A1 Process for the production of citalopram
09/03/2003EP1341403A1 Luminescent element material and luminescent element comprising the same
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340745A1 Indirubin derivatives and their use for the treatment of cancer
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1339799A1 Cyanine dye phosphoramidites
09/03/2003EP1339798A2 Sulfonated diarylrhodamine dyes
09/03/2003EP1339708A2 Indole-type inhibitors of p38 kinase
09/03/2003EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
09/03/2003EP1339683A2 Estrogen receptor modulators
09/03/2003EP1339682A1 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers
09/03/2003EP1339681A1 Synthesis of fused pyrrolecarboxamides
09/03/2003EP1339680A1 Substituted oxindole derivatives as tyrosine kinase inhibitors
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1113822B1 Near infrared fluorescent contrast agent and fluorescence imaging
09/03/2003EP0975588B1 Antipicornaviral compouds, compositions containing them, and methods for their use
09/03/2003EP0910372B1 Pharmaceutical compositions containing mesembrine and related compounds
09/03/2003CN1440390A Substituted diamide derivatives useful as motilin antagonists
09/03/2003CN1440388A Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same
09/03/2003CN1440387A Alpha crystalline form of perindopril tert-butyllamine salt
09/03/2003CN1440386A Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same
09/02/2003US6613944 Process to produce 3-carbon amino alcohol salts
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613803 Treating, preventing or ameliorating pain
09/02/2003US6613794 Inhibiting tumor necrosis factor alpha, treating eosinophil-related condition, treating inflammatory airway disorder
09/02/2003US6613782 For treating and/or preventing endothelin dependent conditions, e.g. cardio- and cerebro-vascular disorders such as hypertension, vasoconstriction, congestive heart failure, cerebral disorders, respiratory system disorders
09/02/2003US6613760 Indole derivatives and their use as MCP-1 receptor antagonists
09/02/2003US6613367 Complete nutrition of infants products are characterized by the type and amount of protein and carbohydrate and the increased levels of folic acid, vitamin B6 and vitamin B12 or their functional equivalents. These products improve feelings
09/02/2003US6613102 As thickening polymer nonionic guar gums; biopolysaccharide gums of microbial origin;
08/2003
08/28/2003WO2003070728A2 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
08/28/2003WO2003070717A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/28/2003WO2003070703A2 Hydroxylated indirubin derivatives
08/28/2003WO2003070691A1 N-hydroxycarboxamide derivative
08/28/2003WO2003070686A1 Substituted phenylalkanoic acid derivative and use thereof
08/28/2003WO2003070247A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/28/2003WO2003049698A3 Substituted hydrazones as inhibitors of cyclooxygenase-2
08/28/2003US20030162970 For use as anti-inflammatory agents
08/28/2003US20030162817 Pentafluorobenzenesulfonamides and analogs
08/28/2003US20030162785 1,3-dihydro-2H-indol- 2-one derivatives
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162761 Androgen receptor targeting agents which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor
08/28/2003US20030162724 Such as tris(4-(N-alpha-(2-(1H-indol-3-yl)acetyl)-L-lysyl)aminophenyl)methane hydrochloride for treatment of thrombocytopenia
08/28/2003CA2476936A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/28/2003CA2476417A1 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders